MarketPulse

osteoarthritis

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Levicept's Osteoarthritis Drug Shows NSAID-Comparable Results Ahead of Major Medical Conference

Levicept will present Phase II data for LEVI-04 at OARSI 2026, showing pain relief comparable to NSAIDs in 518-patient trial published in The Lancet.
PFEdisease modificationpain management
GlobeNewswire Inc.GlobeNewswire Inc.··Mordor Intelligence

Orthobiologics Market Set to Hit $9.5B by 2031 as Regenerative Medicine Surges

Global orthobiologics market projected to grow 43% to $9.52B by 2031, driven by rising osteoarthritis and regenerative therapy advancements.
JNJSYKMDTZBHBVS+1regenerative medicinestem cell therapy